TY - JOUR
T1 - Longitudinal Modeling of the Association between Transmissible Risk, Affect during Drug Use and Development of Substance Use Disorder
AU - Tarter, Ralph E.
AU - Kirisci, Levent
AU - Reynolds, Maureen
AU - Horner, Michelle
AU - Zhai, Zuwei
AU - Gathuru, Irene
AU - Vanyukov, Michael
N1 - Publisher Copyright:
© 2015 American Society of Addiction Medicine.
PY - 2015/12/1
Y1 - 2015/12/1
N2 - Objective: This longitudinal investigation examined the hypothesis that subjective experience during consumption of preferred drugs mediates the association of transmissible risk for substance use disorder (SUD) measured in childhood and adolescence, and SUD diagnosis in adulthood. Transmissible risk denotes the psychological characteristics having intergenerational continuity between parents and their biological children. Methods: The transmissible liability index (TLI) was administered to four hundred eighty-three 10 to 12-year-old boys (baseline). Follow-up evaluations were conducted when the boys attained 12-14, 16, 19, and 22 years of age, using age-specific versions of the TLI. Frequency of consumption of the participants' three most preferred drugs, affect on an ordinary day, affect while under influence of the preferred substances, and presence/absence of current SUD were assessed at 22 years of age. Results: Consumption frequency of preferred drugs among boys mediates the association of transmissible risk during childhood, and adolescence and SUD diagnosis in adulthood. Severity of negative affect on a drug-free day predicts frequency of consumption of preferred drugs, which, in turn, predicts severity of negative affect during the drug use event. Neither affect on a drug-free day nor affect during the drug use event mediates the association of transmissible risk and SUD. Conclusions: Affect on drug-free days, and while under influence of preferred substances, covary with consumption frequency; however, affect is not related to transmissible SUD risk or SUD outcome.
AB - Objective: This longitudinal investigation examined the hypothesis that subjective experience during consumption of preferred drugs mediates the association of transmissible risk for substance use disorder (SUD) measured in childhood and adolescence, and SUD diagnosis in adulthood. Transmissible risk denotes the psychological characteristics having intergenerational continuity between parents and their biological children. Methods: The transmissible liability index (TLI) was administered to four hundred eighty-three 10 to 12-year-old boys (baseline). Follow-up evaluations were conducted when the boys attained 12-14, 16, 19, and 22 years of age, using age-specific versions of the TLI. Frequency of consumption of the participants' three most preferred drugs, affect on an ordinary day, affect while under influence of the preferred substances, and presence/absence of current SUD were assessed at 22 years of age. Results: Consumption frequency of preferred drugs among boys mediates the association of transmissible risk during childhood, and adolescence and SUD diagnosis in adulthood. Severity of negative affect on a drug-free day predicts frequency of consumption of preferred drugs, which, in turn, predicts severity of negative affect during the drug use event. Neither affect on a drug-free day nor affect during the drug use event mediates the association of transmissible risk and SUD. Conclusions: Affect on drug-free days, and while under influence of preferred substances, covary with consumption frequency; however, affect is not related to transmissible SUD risk or SUD outcome.
KW - addiction
KW - children
KW - emotion
KW - etiology
KW - heritable risk
KW - prospective research
UR - http://www.scopus.com/inward/record.url?scp=84957695335&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84957695335&partnerID=8YFLogxK
U2 - 10.1097/ADM.0000000000000163
DO - 10.1097/ADM.0000000000000163
M3 - Article
C2 - 26441401
AN - SCOPUS:84957695335
SN - 1932-0620
VL - 9
SP - 464
EP - 469
JO - Journal of addiction medicine
JF - Journal of addiction medicine
IS - 6
ER -